Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 3
2008 9
2009 1
2010 1
2011 2
2012 5
2013 2
2014 1
2015 3
2017 1
2018 2
2019 7
2020 12
2021 5
2022 11
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy in Sarcoma: Where Do Things Stand?
Moreno Tellez C, Leyfman Y, D'Angelo SP, Wilky BA, Dufresne A. Moreno Tellez C, et al. Among authors: dufresne a. Surg Oncol Clin N Am. 2022 Jul;31(3):381-397. doi: 10.1016/j.soc.2022.03.004. Surg Oncol Clin N Am. 2022. PMID: 35715140 Review.
CIC-DUX4 sarcomas.
Brahmi M, Vanacker H, Macagno N, Tirode F, Dufresne A. Brahmi M, et al. Among authors: dufresne a. Curr Opin Oncol. 2022 Jul 1;34(4):342-347. doi: 10.1097/CCO.0000000000000855. Epub 2022 Jun 22. Curr Opin Oncol. 2022. PMID: 35730520 Review.
Treatment of radiation-associated angiosarcoma.
Dufresne A, Meeus P, Sunyach MP. Dufresne A, et al. Curr Opin Oncol. 2023 Jul 1;35(4):296-300. doi: 10.1097/CCO.0000000000000958. Epub 2023 May 12. Curr Opin Oncol. 2023. PMID: 37222197 Review.
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.
Fazel M, Dufresne A, Vanacker H, Waissi W, Blay JY, Brahmi M. Fazel M, et al. Among authors: dufresne a. Cancers (Basel). 2023 Mar 7;15(6):1643. doi: 10.3390/cancers15061643. Cancers (Basel). 2023. PMID: 36980528 Free PMC article. Review.
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value.
Penel N, Bonvalot S, Le Deley MC, Italiano A, Tlemsani C, Pannier D, Leguillette C, Kurtz JE, Toulmonde M, Thery J, Orbach D, Dubray-Longeras P, Verret B, Bertucci F, Guillemet C, Laroche L, Dufresne A, Blay JY, Le Cesne A. Penel N, et al. Among authors: dufresne a. Int J Cancer. 2023 Jul 15;153(2):407-416. doi: 10.1002/ijc.34493. Epub 2023 Mar 25. Int J Cancer. 2023. PMID: 36883417
[New therapeutic strategies in HER2-positive breast cancer].
Mery B, Toussaint P, Heudel PE, Dufresne A, Carbonnaux M, Vanacker H, Bachelot T, Trédan O. Mery B, et al. Among authors: dufresne a. Bull Cancer. 2021 Jun 15:S0007-4551(21)00215-0. doi: 10.1016/j.bulcan.2021.04.015. Online ahead of print. Bull Cancer. 2021. PMID: 34144793 Review. French.
Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors.
Bouhamama A, Wdowik Q, Grillet F, Brahmi M, Sunyach MP, Vaz G, Meeus P, Gouin F, Corradini N, Dufresne A, Chabaud S, Blay JY, Pilleul F. Bouhamama A, et al. Among authors: dufresne a. J Vasc Interv Radiol. 2023 Sep;34(9):1538-1546. doi: 10.1016/j.jvir.2023.05.012. Epub 2023 May 12. J Vasc Interv Radiol. 2023. PMID: 37182669
New Drug Approvals for Sarcoma in the Last 5 Years.
Thirasastr P, Brahmi M, Dufresne A, Somaiah N, Blay JY. Thirasastr P, et al. Among authors: dufresne a. Surg Oncol Clin N Am. 2022 Jul;31(3):361-380. doi: 10.1016/j.soc.2022.03.003. Surg Oncol Clin N Am. 2022. PMID: 35715139 Review.
74 results